XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Shares outstanding, beginning of the period (in shares) at Dec. 31, 2021   375.5      
Shareholders equity, beginning balance at Dec. 31, 2021 $ (293.9) $ 0.0 $ 2,448.1 $ (2,739.4) $ (2.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   10.8      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (3.9)      
Shares withheld related to net share settlement of restricted stock units and awards (91.0)   (31.4) (59.6)  
Repurchases of common stock (in shares)   (27.6)      
Repurchases of common stock (621.1)   (223.1) (398.0)  
Exercise of stock options and awards (in shares)   0.1      
Exercise of stock options and awards 0.4   0.4    
Tax benefit attributable to bond hedges purchased in connection with issuance of convertible senior notes 1.5   1.5    
Stock-based compensation 243.4   243.4    
Other comprehensive income (loss) (55.5)       (55.5)
Net income 224.9     224.9  
Shares outstanding, end of the period (in shares) at Sep. 30, 2022   354.9      
Shareholders equity, ending balance at Sep. 30, 2022 (591.3) $ 0.0 2,438.9 (2,972.1) (58.1)
Shares outstanding, beginning of the period (in shares) at Jun. 30, 2022   360.3      
Shareholders equity, beginning balance at Jun. 30, 2022 (542.9) $ 0.0 2,424.1 (2,926.1) (40.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.5      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.2)      
Shares withheld related to net share settlement of restricted stock units and awards (29.6)   (9.6) (20.0)  
Repurchases of common stock (in shares)   (7.7)      
Repurchases of common stock (171.4)   (62.2) (109.2)  
Exercise of stock options and awards 0.1   0.1    
Tax benefit attributable to bond hedges purchased in connection with issuance of convertible senior notes 0.4   0.4    
Stock-based compensation 86.1   86.1    
Other comprehensive income (loss) (17.2)       (17.2)
Net income 83.2     83.2  
Shares outstanding, end of the period (in shares) at Sep. 30, 2022   354.9      
Shareholders equity, ending balance at Sep. 30, 2022 (591.3) $ 0.0 2,438.9 (2,972.1) (58.1)
Shares outstanding, beginning of the period (in shares) at Dec. 31, 2022   349.4      
Shareholders equity, beginning balance at Dec. 31, 2022 $ (309.4) $ 0.0 2,511.6 (2,772.1) (48.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   11.5      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (4.1) (4.1)      
Shares withheld related to net share settlement of restricted stock units and awards $ (100.6)   (37.1) (63.5)  
Repurchases of common stock (in shares)   (18.8)      
Repurchases of common stock $ (436.1)   (170.7) (265.4)  
Exercise of stock options and awards (in shares) 0.2 0.2      
Exercise of stock options and awards $ 2.4   2.4    
Stock-based compensation 255.1   255.1    
Other comprehensive income (loss) 12.0       12.0
Net income 226.3     226.3  
Shares outstanding, end of the period (in shares) at Sep. 30, 2023   338.2      
Shareholders equity, ending balance at Sep. 30, 2023 (350.3) $ 0.0 2,561.3 (2,874.7) (36.9)
Shares outstanding, beginning of the period (in shares) at Jun. 30, 2023   339.6      
Shareholders equity, beginning balance at Jun. 30, 2023 (411.9) $ 0.0 2,521.9 (2,895.6) (38.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.5      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.2)      
Shares withheld related to net share settlement of restricted stock units and awards (34.4)   (11.0) (23.4)  
Repurchases of common stock (in shares)   (3.8)      
Repurchases of common stock (104.4)   (34.6) (69.8)  
Exercise of stock options and awards (in shares)   0.1      
Exercise of stock options and awards 1.2   1.2    
Stock-based compensation 83.8   83.8    
Other comprehensive income (loss) 1.3       1.3
Net income 114.1     114.1  
Shares outstanding, end of the period (in shares) at Sep. 30, 2023   338.2      
Shareholders equity, ending balance at Sep. 30, 2023 $ (350.3) $ 0.0 $ 2,561.3 $ (2,874.7) $ (36.9)